Emerging drugs for preeclampsia – the endothelium as a target

Bibliography

• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-99
   PubMed Web of Science ®Google Scholar
• George EM, Granger JP. Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. Hypertension 2012;60:507-11
   PubMed Web of Science ®Google Scholar
• Berzan E, Doyle R, Brown CM. Treatment of preeclampsia: current approach and future perspectives. Curr Hypertens Rep 2014;16(9):473
   PubMed Web of Science ®Google Scholar
• Goulopoulou S, Davidge ST. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med 2015;21:88-97
   PubMed Web of Science ®Google Scholar
• Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009;30:473-82
   PubMed Web of Science ®Google Scholar
• George EM, Granger JP. Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep 2011;13:269-75
   PubMed Web of Science ®Google Scholar
• George EM, Granger JP. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 2011;24(9):964-9
   PubMed Web of Science ®Google Scholar
• Wareing M, Myers JE, O’Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 2005;90:2550-5
   PubMed Web of Science ®Google Scholar
• Maharaj CH, O’Toole D, Lynch T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol 2009;7:34
   PubMed Web of Science ®Google Scholar
• George EM, Palei AC, Dent EA, Granger JP. Sildenafil attenuates placental ischemia-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2013;305(4):R397-403
   Google Scholar
• Stanley JL, Andersson IJ, Poudel R, et al. Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension 2012;59:1021-8
   PubMed Web of Science ®Google Scholar
• Turgut NH, Temiz TK, Bagcivan I, et al. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol 2008;589:180-7
   PubMed Web of Science ®Google Scholar
• Samangaya RA, Mires G, Shennan A, et al. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregnancy 2009;28:369-82
   PubMed Web of Science ®Google Scholar
• Sasser JM, Baylis C. Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol 2010;298:R433-8
   Google Scholar
• Lin TH, Su YN, Shih JC, et al. Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy. Ultrasound Obstet Gynecol 2012;40(5):609-10
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 2011;118(5):624-8
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Alfirevic Z, Von Dadelszen P, et al. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Syst Rev 2014;3:23
   PubMedGoogle Scholar
• Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999;353:133-8
   PubMed Web of Science ®Google Scholar
• Motte S, McEntee K, Naeije R. Endothelin receptor antagonists. Pharmacol & Ther 2006;110:386-414
   PubMed Web of Science ®Google Scholar
• Verdonk K, Saleh L, Lankhorst S, et al. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying Renin-Angiotensin-aldosterone system suppression. Hypertension 2015;65(6):1316-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25870197
   Google Scholar
• George EM. New approaches for managing preeclampsia: clues from clinical and basic research. Clin Ther 2014;36(12):1873-81
   PubMed Web of Science ®Google Scholar
• Jain A. Endothelin-1: a key pathological factor in pre-eclampsia? Reprod Biomed Online 2012;25(5):443-9
   PubMed Web of Science ®Google Scholar
• Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy 2012;2012:586578
   PubMedGoogle Scholar
• Stein PD, Hunt JT, Floyd DM, et al. The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide. J Med Chem1994;37(3):329-31
   PubMed Web of Science ®Google Scholar